SCRI - Maryland Oncology Hematology, P.A. — Annapolis, Maryland

SCRI - Maryland Oncology Hematology, P.A. is a clinical research site located in Annapolis, Maryland, United States 21401.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI - Maryland Oncology Hematology, P.A. has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer.

Sponsors: TORL Biotherapeutics, LLC.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI - Maryland Oncology Hematology, P.A.?

SCRI - Maryland Oncology Hematology, P.A. has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI - Maryland Oncology Hematology, P.A. conducted?

SCRI - Maryland Oncology Hematology, P.A. has 1 clinical trials on record, with 1 currently active. Their work covers Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer.

Is SCRI - Maryland Oncology Hematology, P.A. accredited by Crixeo Health?

SCRI - Maryland Oncology Hematology, P.A. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI - Maryland Oncology Hematology, P.A.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.